Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase IIa Study of AIDS Vaccine (Combined Use of DNA Vaccine and Recombinant Vaccinia Virus Tiantan)

NCT01705223 is registered in ClinicalTrials.gov with National Center for AIDS/STD Control and Prevention, China CDC as lead sponsor.

NCT NCT01705223
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01705223 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase IIa Study of AIDS Vaccine (Combined Use of DNA Vaccine and Recombinant Vaccinia Virus Tiantan)
Lead sponsor
National Center for AIDS/STD Control and Prevention, China CDC
Phase
Phase 2
Overall status
Completed
Start date
August 31, 2012
Completion date
January 31, 2015
Enrollment
150 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aids